John Locke Foundation: Prudent Policy / Impeccable Research - Volume XIV | Eastern NC Now

We will offer this allotment of three with more to come; some old, most new, but all quite informative, and, moreover, necessary to understanding that in North Carolina, there is a wiser path to govern ourselves and our People.

ENCNow
Home
Categories
Login
Advertisement
VbAD0
Latest Polls   (view all)
Where do you stand on the Transgender Issue now that the issue has gotten to the overt point of the open celebration of this lifestyle choice, dictated by certain direct and explicit actions.
90.52% I do not approve of behavior that has within its expressed tenants policies that harm children.
8.62% I do support the Trans Community in all its many facets because diversity is at a premium in today's society.
0.86% What is a "Children's Drag Queen Story Hour?"
Advertisement
VbAD1
Latest Comments   (view all)
Advertisement
VbAD2
Latest Entries   (view all)
Advertisement
VbAD3
ENCN Masthead
ENCN Masthead
Go Back


Leave a Guest Comment

Your Name or Alias
Your Email Address ( your email address will not be published )
Enter Your Comment ( text only please )




Obama told us what he was going to do and he's doing it John Locke Foundation Guest Editorial, Editorials, Op-Ed & Politics Hagan: "Dahling, she loves you but give her Park Avenue ..."


HbAD0

Latest Op-Ed & Politics

this will help populist anti-immigration right in next year's presidential election
Unloaded on President Donald Trump in a series of profanity-laced private text messages

HbAD1

The tour bus will make 63 stops across 13 states across the country, and will end on Election Day in November.
the need for a pro-America curriculum in our schools

HbAD2

Organizations are quietly using foreign money to move the needle toward their preferred political outcomes.
illegal alien "asylum seeker" migrants are a crime wave on both sides of the Atlantic
Democrats are still calling Israel the biggest foreign lobby in America — and they’re using it to win the 2026 midterms.

HbAD3

 
 
Back to Top